(528 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Harmonization of clinical outcomes of efficacy in Food-AIT trialsObjectives: Evaluate clinical efficacy outcomes of Food AIT.Understand how the use of diff...
-
MicronutrientsAtopic diseases are associated with an exaggerated immune response to harmless antigens du...
-
E-learning material about AllergoOncologyAllergoOncology was a TF of the Immunology Section. During 2020, it experienced a transiti...
-
CRS EndotypesChronic rhinosinusitis (CRS) is defined as an inflammatory disease of the nose and paranas...
-
Human Skin MicrobiotaHuman skin is a complex and dynamic ecosystem with specific characteristics that vary depe...
-
Ultraprocessed foods and allergy outcomes: Stopping a global epidemicPrevalence and severity of allergic diseases in the European pediatric populations increas...
-
Blister fluid analysis in allergic diseasesInternational research efforts significantly advanced our understanding of the local infla...
-
Macrophage role in Allergy and Cancer: Novel therapeutic opportunitiesMacrophages are heterogeneous immune cells present in all tissues, which plasticity allows...
-
Omic technologies in allergy researchOmics technologies constitute an essential tool in the research of precision and personali...
-
High altitude climate treatmentHigh altitude climate therapy (HACT) combines multidisciplinary treatment with environment...
-
Public outreach for immunological mechanisms in allergies and asthmaIn Europe, approximately 150 million citizens suffer from chronic allergic diseases and 7 ...
-
Cannabis Allergy Working GroupThe international Cannabis Allergy Working Group was established in 2020 by EAACI, togethe...
-
Improving Chronic Urticaria Management in Pediatrics - (ICUMP)Urticaria is a cutaneous mast cell-driven disease, characterized by the spontaneous develo...
-
Validation of Clinical endpoints in AIT (with MASK technology)In 2014, the EAACI has published a Position Paper on “clinical endpoints in AIT”. The ...
-
Anti-inflammatory effect of anti-muscarinic antagonistsInhaled long-acting muscarinic antagonists (LAMA) are the cornerstone of COPD treatment. G...
-
One Health in AllergologyAllergic diseases are still on the rise in both humans and domestic animals. For all mamma...
-
ENIGMA (Exploring Non-IgE mediated Allergy)The ENIGMA (Exploring non-IgE mediated Allergy) Task Force (TF) was established in 2018 wi...
-
Feeding difficulties in children with food allergiesIntroduction. Feeding difficulties range from avoidance of single foods/food groups to avo...
-
Conscious and rational use of antibiotics in allergic diseasesAntibiotics are one of the most frequently prescribed medicines; therefore antimicrobial r...
-
Interdisciplinary TF group “Definition of clinical-relevant thresholds of allergen-exposure for analysis of outcomes in AIT”_ Phase IIIPHASE 5Critical steps in 2021 Following the first publication of our definitions of Pollen...
-
EAACI Food Allergy GuidelinesWe are planning the following publications for 2022: 1. Systematic review of the literatur...
-
Understanding hypersensitivity reactions to COVID 19 vaccinesCOVID-19 vaccines are based on different vaccine platforms based on nucleic acids, artific...
-
EAACI JM Collaboration with European Rhinologic Society (ERhS) Junior Member (JM) CommitteeThe EAACI JM collaboration with juniors of the ERhS was established in 2016. It has given ...
Show more Task Forces (21)Show Less-
-
Allergen composition of preparations translate into clinical outcomes of AITWelcome and introduction Suzanne Lau ...
-
A transformational approach to managing allergies to catsIntroduction Antonella Muraro ...
-
Type 2 Inflammation: What every clinician should knowHans In‘t Veen, Jasper Kappen This Company Sponsored Symposia...
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
Clinical Cases in discussion: 3 patients, 3 experts & 1 solutionPablo Rodríguez Del Río, Torsten Zuberbier, Fulvio Braido, Mélisande Rouger
-
Peanut allergy and investigational DBV712: an updateIntroduction Antonella Muraro ...
-
Re-thinking lung function testing in young children
-
A novel dual key solution to unlock the treatment of allergic rhinitisClinical challenges and management strategies in allergic rhinitis: where are we? ...
-
Exploring the Complexity of Chronic Spontaneous UrticariaChronic Spontaneous Urticaria (CSU): unpredictable, chronic and burdensome ...
-
Chronic spontaneous urticaria: defining the pathway to successful managementWelcome and Introduction Marcus Maurer ...
-
MicroCrystalline Tyrosine-associated allergoids: Reaching the top of the evidence pyramidRalph Mösges
-
How can we improve the approach to treating chronic urticaria in children?Introduction Montserrat Alvaro Lozano ...
-
Pioneering a new age – fighting allergic disease on all fronts!Introduction video Introducti...
-
Everything you always wanted to know about SCIT but were afraid to askSCIT: Long-term efficacy Andrzej Bozek ...
-
Furthering AIT`s promises with precision medicineOpening remarks G.Walter Canonica ...
-
IgE in asthma and nasal polyposis: your questions answered
-
Allergen immunotherapy with allergoid-mannan conjugates: from basic science to clinical researchIntroduction The allergoid-ma...
-
Mind the PAF: a new route to managing chronic urticaria and allergic diseases?Welcome address Frank Siebenhaar ...
-
To eat or not to eat: that is the questionNutrition and gut health for prevention of food allergy ...
-
Mite – the “diva” in AIT trialsWelcome and introduction Fill...
-
Allergic patient: The Real WorldIntroduction European patient...
-
Improving patients’ journeys in food allergyWelcome and introduction Alexandra Santos ...
-
Evolving patient journeys in food allergyWelcome and Introduction Ses...
-
Expansion of Hydrolysed Rice Formula for Infants with Cow’s Milk Allergy: Considerations for Clinical PracticeExpansion of Hydrolysed Rice Formula for Infants with Cow’s Milk Allergy: Considerations...
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseasesWelcome and introduction Peter Howarth, G....
-
Exploring the Role of Type 2 Inflammation in Dermatologic DiseasesAtopic Dermatitis and the Type 2 Inflammatory Disease Spectrum ...
-
SCIT; pioneering a new eraIntroduction Venom Immunothe...
-
Optimising AIT clinical practice: the patient, the evidence, and the futureOpening video Chair’s welco...
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascadeIoana Agache, Andrew Menzies-gow, Stephanie Korn, Celeste Porsbjerg
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Looking ahead to the future: Advances in HAE diagnosticsLooking ahead to the future: Advances in HAE diagnostics ...
-
Advances in eosinophilic diseases
-
How do HMO modulate the immune system in infants with CMPA? emerging evidence and clinical implications.Introduction Clinical implica...
-
Shining a light on unmet needs in HAE special patient populationsWelcome and introduction The ...
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Advancing the management of CMPA with HMO: Priming the immune systemIntroduction The clinical rel...
-
Exploring new horizons: The future of Hereditary Angioedema treatmentWelcome and Introductions Und...
-
Targeting eosinophils in severe asthma: real-world data and clinical remissionChair’s welcome Biologics ...
-
Treating peanut allergy with oral immunotherapy: new data and practical experienceIntroduction Jonathan O’B Hourihane ...
-
Biologics in CRSwNP: Comparative Efficacy and Real-World Effectiveness
-
Relegating OCS to last resort: Creating a paradigm shift in asthma managementAstraZeneca: Relegating OCS to last resort: Creating a paradigm shift in asthma management...
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 InflammationOpening remarks Santiago Quirce ...
-
The complex world of allergy. Patient’s needs in real lifeThe complex world of allergy. Patient’s needs in real life ...
-
Supporting individual patients’ needs: AIT still an unmatched model of personalized medicine for allergy
-
Patients with peanut allergy: the hope for a better life?Introduction Antonella Muraro ...
-
Efficacy and quality of life in HAE: The lanadelumab experience
-
Targeting Type 2 mechanisms in patients with atopic dermatitis and comorbid Type 2 Inflammatory disease: A case-based reflectionConnecting Type 2 Inflammation to clinical characteristics of disease
-
Updates on molecular allergology & food allergen componentsWelcome & Introduction Philippe Eigen...
-
Path to improving patient care in hereditary angioedema (HAE): what are the treatment goals and how can they be achieved?Welcome and introduction Marcus Maurer ...
-
Reconsider the art of AITWelcome and introduction Pati...
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?Welcome & Introduction Jonathan Grigg...
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Patients’ perspective : a must have for the future of Allergen ImmunotherapyIntroduction What can a patie...
-
Navigating Type 2 Inflammation across the skin, airway, and esophagusNavigating Type 2 Inflammation across the skin, airway, and esophagus ...
-
Clinical puzzles: Precision diagnostics in personalized medicine - Discover the connectionWelcome & Introduction C...
-
Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?Reflection on hereditary angioedema (HAE): Progress and perspectives ...
Show more Sponsored Symposia (57)Show Less-
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendationsAbstract Immune modulation is a key therapeutic approach for allergic diseases, asthma an...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria TaskforceAbstract Background: Although well described in adults, there are scarce and heterogene...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives - A report of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract With the worldwide spread of the novel severe acute respiratory syndrome coronav...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2Abstract The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the se...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperAbstract Because of the inflammatory mechanisms of most chronic upper airway diseases suc...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityAbstract Immediate and nonimmediate hypersensitivity reactions to iodinated contrast medi...
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperAbstract Background: Chronic rhinosinusitis is regarded as a chronic airway disease. Acc...
-
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperAbstract The immune system interacts with many nominal ‘danger’ signals, endo...
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animalsAbstract Adverse reactions to insects occur in both human and veterinary patients. System...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence NetworkAllergy, Asthma and Clinical Immunology Research has many challenges, including complex Eu...
-
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer - a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Elevated serum IgE levels are associated with allergic disorders, parasitosis an...
-
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disordersREAD HERE
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)Abstract Therapeutic advances using targeted biologicals and small-molecule drugs have ac...
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position PaperAbstract Multisystem inflammatory syndrome in children (MIS-C) is a rare, but severe comp...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
Show more Position Papers (71)Show Less-
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
How to improve outcomes
-
New and clinically relevant contact allergens
-
BAT in clinical practice. Is it possible?
-
Differential diagnosis
-
Delabelling adults
-
AIT in the pediatric population
-
Launch of the Biological guidelines
-
Novel pharamacological targets
-
Inflammatory biomarkers
-
Do adrenaline auto-injectors save lives?
-
Big Data Analysis: MetabolomicsView Presentation
-
Electronic Health in Severe Asthma
-
Psychological support to peanut allergic children and their families
-
The underlying immunology of pruritus
-
AAAAI Practice Parameters
-
The basics of severe asthma - biomarkers
-
Difficult to control asthma in adults
-
The clinical clues and pitfalls in contact dermatitis
-
Role Viral reactivations
-
Molecular allergology in daily clinical practice
-
Tackling anaphylaxis
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
AI models
-
Hypereosinophilic syndromes and autoimmunity
-
New insights in urticaria mechanisms
-
Oral food challenges thresholds for clinical reactions
-
Environmental epigenomics of allergy
-
Microbiota in immune-based therapies
-
An update on food allergy
-
When hives are not chronic urticaria
-
Air pollution and allergy: call for action!
-
Immunological basis of food aversion
-
Bronchial allergen challenge in research
-
It looks like urticaria – but is it?
-
Immune modulation in local allergic rhinitis
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Epithelial cell barrier and allergic diseases
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
Living with food allergy
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Diagnosis of insect venom allergy: back to basics
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Precision Medicine and AIT
-
Impact of climate change on the immune system
-
B cells in in chronic rhinosinusitis: friend or foe
-
Probiotics and prebiotics: an on-going journey
-
Impacting quality of life with PALFORZIA
-
An update on prevention of allergic diseases
-
Difficult to control asthma in children
-
EAACI Guidelines on environmental health
-
Predicting adverse reactions to biologicals
-
How to select and follow a biological for asthma and CRSwNP
-
Current and future perspectives
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Chronic rhinosinusitis with nasal polyps
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Preparing a grant: Dos and Don'ts
-
Exercise-induced urticaria and anaphylaxis
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Update on drug allergy
-
Eosinophilic fasciitis, an unusual presentation
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Big data and cluster analysis: a real life perspective
-
Autoimmunity in atopic diseases
-
GINA Guidelines Update
-
What’s different about the adolescent brain?
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Gut microbiome - based therapeutic approaches
-
Non-T2 directed biologicals
-
The dilemma of food allergy additives
-
Mechanisms of non IgE mediated food allergy
-
Covid-19 in "Allergy" journal
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Wild-fires, pollution, climate change and other threats
-
Lung function testing
-
Global impact of the COVID-19 on the environment
-
Innate trained immunity: An evolutionary perspective
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
The role of infection in chronic spontaneous urticaria
-
Phenotypes and Endotypes
-
Potential biomarkers for diagnosis and treatment for CSU
-
The brain, nose, immune axis
-
Hologenome and obesity
-
Viral infection and asthma
-
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Implementing component resolved diagnostics in allergy diagnosis
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Skin care from birth for allergy prevention: results today
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
We are what we eat - importance of food to health, moving past simple calories
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Allergy to Kale
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Precision medicine in immunodeficiency
-
Neuroimmunology and allergy
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
EAACI Guideline on NAR: does it need to be updated?
-
Is IgA a piece of the EoE puzzle?
-
Unmet needs in immunological mechanisms in AIT: key cellular playersView Presentation
-
Is anaphylaxis really rare in children?
-
Update of the WAO anaphylaxis guidance
-
Exercise: induced asthma and rhinitis
-
Hypersensitivity to antiepileptic drugs
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
COVID-19 Vaccination: Separating facts from fiction for your patients
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Characterization of the immunological properties of different β-glucans on myeloid dendritic cells
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Practical Course on Big data analysis: transcriptomics, metabolomics, CyTOF and flow cytometryView Presentation
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
E-cigarettes: mechanistic link to lung injury
-
How to use social media in your professional practice: the clinician perspective
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-